Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Open-label Phase II Study Evaluating the Efficacy and Safety of Folfox6 + Cetuximab as First-line Therapy in Patients With Metastatic Colorectal Cancer

NCT00286130 is registered in ClinicalTrials.gov with Central European Cooperative Oncology Group as lead sponsor.

NCT NCT00286130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00286130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Open-label Phase II Study Evaluating the Efficacy and Safety of Folfox6 + Cetuximab as First-line Therapy in Patients With Metastatic Colorectal Cancer
Lead sponsor
Central European Cooperative Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2005
Completion date
October 31, 2007
Enrollment
150 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer